The two main membrane filtration methods are Direct Flow Filtration (DFF) and Tangential Flow Filtration (TFF). Both methods can be used for the concentration of exosomes
Direct Flow Filtration vs Tangential Flow Filtration
DFF also called “dead-end filtration”, has a feed stream that is perpendicular to the filtration membrane, so the feed must pass straight through the membrane to be filtered.
In DFF the pores of the membrane may become blocked by
larger particles making it difficult for the smaller particles to pass
through the filter. As a result, this can cause the feed flow to reduce
dramatically, requiring increased pressure to be applied to the fluid so
that smaller particles can eventually pass through the membrane.
TFF has a feed stream that passes parallel to the filtration membrane, so the feed passes across the surface of the fliter..
In TFF, as the feed passes across the surface of the membrane, this constant agitation in the feed flow prevents blockage
of the membrane, making TFF a fast and efficient method for the
purification, concentration and buffer exchange of exosome samples.
In TFF what passes through the membrane is called the permeate and what is retained is called the retentate. The retentate can then be recirculated to the feed reservoir until the desired concentration of the sample has been achieved.
Concentrating EV samples with HansaBioMed TFF-easy.
HansaBioMed TFF-Easy is a filter cartridge made from polysulfone hollow fibres with 20 nm pores and based on the tangential flow filtration methodology as described above. It allows the concentration and the removal of small proteins and molecules from diluted matrices (cell conditioned media, urine, etc..) prior to the EV purification and EV dialysis for changing buffer conditions. Water and small molecules (<20 nm) pass through the hollow fibre pores and are collected in the collection bag and extracellular vesicles can be easily recovered from the hollow fibre cartridge with a syringe.
The protocol is simple, using a syringe containing the sample at one end and a clean empty syringe at the other. Then to start the concentration process, simply push the two syringes alternately until the desired volume has been obtained.
Comparison between TFF-easy and MWCO spin concentrator.
When compared with the MWCO spin concentrator in an ELISA assay assessing the expression of CD81 in LnCAP CCM, TTF-easy showed better performance and low variability between samples as seen in the graph below.
Combine TFF-easy with the HansaBioMed Size exclusion Chromatography Columns to obtain Pure Exosomes and Extracellular Vesicles.
Ultracentrifugation is currently the gold standard methodology for Extracellular Vesicle isolation from biological fluids or cell conditioned media. However, it does not isolate EVs efficiently, tends to alter the vesicle shape and functionality, requires expensive equipment and is time-consuming. To address these issues, HBM-LS has developed optimised tools for the isolation of total or specific EV populations.
In particular, HansaBioMed-LS has developed different classes of Size Exclusion Chromatography columns from different sample matrices and volumes (from 100ul and up to 20 mL). Size exclusion chromatography is currently one of the best methods to isolate exosomes and EVs. As a result, using TFF-easy to concentrate samples before using the PureEV SEC columns from HansaBioMed allows researchers to isolate easily and efficiently highly pure exosomes and EVs for further studies.
27/06/2018
13/06/2018
First Commercially Available Active Human and Mouse ASYN Proteins from StressMarq
Alpha-synuclein is a 140 amino acid protein which in humans, is encoded by the SNCA gene. It is expressed predominantly in the brain and particularly in presynaptic nerve terminals.
Due to its structural flexibility, alpha-synuclein can adopt several conformations and depending on the environment and the binding partners, exists as a dynamic balance between monomeric unfolded and an amphipathic alpha-helix (membrane binding) states.
In healthy brains, quality control systems ensure the correct assembly of alpha-synucleins and intracellular alpha-synuclein homeostasis is controlled via the ubiquitin-proteasome system and the lysosomal autophagy system, with the latter being involved in clearing oligomer assemblies. Other synucleins are also able to inhibit and control the oligomerisation of alpha-synuclein.
Failure in these systems, oxidative stress, pH changes are, to name a few, examples of triggers that can lead to the overproduction and accumulation of alpha-synuclein. In addition, post-translational modifications of alpha-synuclein can lead to a change in conformation resulting in the alpha-synuclein proteins being more susceptible to aggregation. In Lewy bodies, it has been shown that phosphorylated Ser129 alpha-synuclein is the most abundant form of alpha-synuclein present in these aggregates.
In pathological conditions such as Parkinson’s disease, soluble alpha-synuclein monomers associate to form oligomers that will combine further to generate protofibrils that subsequently aggregate to form large and insoluble aggregates, the main component of Lewy body inclusions.[1] These neurotoxic aggregates will cause the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta, causing the motor symptoms in PD. [2]
StressMarq has recently released the first commercially available active Human and Mouse Alpha Synuclein Monomers and Pre-formed Fibrils:
- Active Human Recombinant Alpha Synuclein Protein Monomer (Cat No. SPR-321)
- Active Human Recombinant Alpha Synuclein Pre-Formed Fibrils (Cat No. SPR-322).
- Active Mouse Recombinant Alpha Synuclein Protein Monomer (Cat No. SPR-323)
- Active Human Recombinant Alpha Synuclein Pre-Formed Fibrils (Cat No. SPR-324).
The active alpha synuclein pre-formed fibrils (Cat No. SPR-322) in presence of the active alpha-syn monomer (SPR-321) has been shown to induce Lewy body inclusion formation in neuronal cell culture, a characteristic of Parkinson’s Disease.
This was demonstrated using T-thioflavin, a fluorescent dye that binds to beta sheet-rich structures, such as those in α-Syn aggregates and which upon binding, experiences a red-shift in its emission spectrum and increased fluorescence intensity. As seen in the images below, it was shown that 10 nM of active α-Syn aggregate (SPR-322) combined with 100 µm of active α-Syn monomer (SPR-321) could induce aggregation, as compared to active α-Syn aggregate (SPR-322) and active α-Syn monomer (SPR-321) alone.
A similar experiment was also performed to show the activity of the active mouse pre-formed fibrils and monomers (SPR 323 and SPR324).
In addition, StressMarq has also launched control alpha synuclein protein monomers (Cat No. SPR-316) and control alpha synuclein protein aggregates (Cat No. SPR-317) which are inactive as shown in the image below.
These active alpha synuclein proteins and the related alpha synuclein antibodies below can be purchased in the UK and Ireland via Newmarket Scientific, the distributor of StressMarq.
StressMarq alpha synuclein antibodies: | Cat. No. |
---|---|
Alpha synuclein, clone 3C11 | SMC-530 |
Alpha synuclein, clone 10H7 | SMC-531 |
Alpha synuclein, clone 3F8 | SMC-532 |
Alpha synuclein, clone 4F1 | SMC-533 |
Alpha synuclein pSer129 | SPC-742 |
References:
[1] Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration, Ghiglieri V. et al, Front Neurol. 2018; 9 : 295
[2] Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease, Gelders G. et al, J Immunol Res., 2018: 4784268. doi: 10.1155/2018/4784268. eCollection 2018.
Written by Magalie Dale
If you like my post why not connect to me on LinkedIn.
Subscribe to:
Posts (Atom)